Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10492)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2014 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen F, Zheng RD, Mi YQ, Wang XY, Pan Q, Chen GY, Cao HX, Chen ML, Xu L, Chen JN, Cao Y, Zhang RN, Xu LM, Fan JG. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol 2014; 20(16): 4702-4711 [PMID: 24782622 DOI: 10.3748/wjg.v20.i16.4702] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i16/4702.htm |
| Number | Citing Articles |
| 1 |
Bei Li, Chuan Zhang, Yu-Tao Zhan. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/2784537
|
| 2 |
Yue-Yan Hu, Ning-Ling Dong, Qiu Qu, Xu-Fan Zhao, Hong-Ju Yang. The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients. Medicine 2018; 97(43): e12931 doi: 10.1097/MD.0000000000012931
|
| 3 |
Dieter Broering, Mohamed Shawkat, Ali Albenmousa, Faisal Abaalkhail, Saleh Alabbad, Waleed Al-Hamoudi, Saad Alghamdi, Saleh Alqahthani, Ahmad Jaafari, Roberto Troisi, Khalid Bzeizi, Frank JMF Dor. Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors. PLOS ONE 2021; 16(5): e0251487 doi: 10.1371/journal.pone.0251487
|
| 4 |
Sebastian Zenovia, Cristina Muzica, Mihaela Dimache. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 107 doi: 10.1007/978-3-031-33548-8_10
|
| 5 |
Charlotte Wernberg, Mie Balle Hugger, Maja Thiele. Liver Elastography. 2020; : 441 doi: 10.1007/978-3-030-40542-7_38
|
| 6 |
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography. Cancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
|
| 7 |
Amjad M. Ahmed, Mohamed E. Ebid, Amr M. Ajlan, Mouaz H. Al-Mallah. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease. Abdominal Radiology 2017; 42(10): 2454 doi: 10.1007/s00261-017-1166-8
|
| 8 |
Arinc Ozturk, Joseph R. Grajo, Michael S. Gee, Alex Benjamin, Rebecca E. Zubajlo, Kai E. Thomenius, Brian W. Anthony, Anthony E. Samir, Manish Dhyani. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance. Ultrasound in Medicine & Biology 2018; 44(12): 2461 doi: 10.1016/j.ultrasmedbio.2018.07.019
|
| 9 |
Jian Gao Fan, Lai Wei, Hui Zhuang. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). Journal of Digestive Diseases 2019; 20(4): 163 doi: 10.1111/1751-2980.12685
|
| 10 |
Paula Iruzubieta, Marta González, Joaquín Cabezas, María Teresa Arias-Loste, Javier Crespo. Liver Research and Clinical Management. 2018; doi: 10.5772/intechopen.72668
|
| 11 |
Monica Lupsor-Platon, Radu Badea. Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan<sup>®</sup>). World Journal of Gastroenterology 2015; 21(42): 11914-11923 doi: 10.3748/wjg.v21.i42.11914
|
| 12 |
Vincent Wai-Sun Wong, Salvatore Petta, Jean-Baptiste Hiriart, Calogero Cammà, Grace Lai-Hung Wong, Fabio Marra, Julien Vergniol, Anthony Wing-Hung Chan, Antonino Tuttolomondo, Wassil Merrouche, Henry Lik-Yuen Chan, Brigitte Le Bail, Umberto Arena, Antonio Craxì, Victor de Lédinghen. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. Journal of Hepatology 2017; 67(3): 577 doi: 10.1016/j.jhep.2017.05.005
|
| 13 |
Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abd Hamid, Ngiu Chai Soon, Shamsul Azhar Shah, Yazmin Yaakob, Raja Affendi Raja Ali. Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease. International Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9252536
|
| 14 |
Karolina Grąt, Michał Grąt, Olgierd Rowiński. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2020; 8(9): 298 doi: 10.3390/biomedicines8090298
|
| 15 |
Yuanlong Sun, Gaofeng Chen, Si Chen, Yanjie Wang, Yiyang Hu, Yu Zhao. Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial. Trials 2022; 23(1) doi: 10.1186/s13063-022-06393-8
|
| 16 |
Jing Chen, Meng-Lan Wang, Qin Long, Lang Bai, Hong Tang. High value of controlled attenuation parameter predicts a poor antiviral response in patients with chronic hepatits B. Hepatobiliary & Pancreatic Diseases International 2017; 16(4): 370 doi: 10.1016/S1499-3872(16)60144-3
|
| 17 |
Xinyu Yang, Xinxia Chang, Shengdi Wu, Xiaoyang Sun, Xiaopeng Zhu, Liu Wang, Yushan Xu, Xiuzhong Yao, Shengxiang Rao, Xiqi Hu, Mingfeng Xia, Hua Bian, Hongmei Yan, Xin Gao. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01453-5
|
| 18 |
Wah‐Kheong Chan, Nik Raihan Nik Mustapha, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Sanjiv Mahadeva. Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non‐alcoholic fatty liver disease in an Asian population. United European Gastroenterology Journal 2017; 5(1): 76 doi: 10.1177/2050640616646528
|
| 19 |
Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trial. Clinical and Experimental Pediatrics 2022; 65(6): 304 doi: 10.3345/cep.2021.00787
|
| 20 |
Jing Chen, Dongbo Wu, Menglan Wang, Enqiang Chen, Lang Bai, Cong Liu, Juan Liao, Hong Tang. Controlled attenuation parameter for the detection of hepatic steatosis in patients with chronic hepatitis B. Infectious Diseases 2016; 48(9): 670 doi: 10.3109/23744235.2016.1165860
|
| 21 |
Ma Ai Thanda Han, Rola Saouaf, Walid Ayoub, Tsuyoshi Todo, Edward Mena, Mazen Noureddin. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD). Expert Review of Clinical Pharmacology 2017; 10(4): 379 doi: 10.1080/17512433.2017.1299573
|
| 22 |
Jinfei Tang, Ergang Du, Xingyu Li. Combined Surgical Techniques for the Management of Malignant Glaucoma. Journal of Ophthalmology 2018; 2018: 1 doi: 10.1155/2018/9189585
|
| 23 |
梦昆 李. Correlation Analysis of LIPA rs1051338 and Risk of Non-Alcoholic Fatty Liver Disease in Chinese Han Population. Advances in Clinical Medicine 2024; 14(05): 1891 doi: 10.12677/acm.2024.1451631
|
| 24 |
Monica Lupsor-Platon. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71161
|
| 25 |
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>®</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?. World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
|
| 26 |
Andrea Pasta, Paolo Borro, Anna Laura Cremonini, Elena Formisano, Giulia Tozzi, Stefano Cecchi, Raffaele Fresa, Sara Labanca, Afscin Djahandideh, Samir Giuseppe Sukkar, Antonino Picciotto, Livia Pisciotta. Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single‐center observational study. Pharmacology Research & Perspectives 2021; 9(5) doi: 10.1002/prp2.820
|
| 27 |
Taranika Sarkar Das, Xucong Meng, Mohamed Abdallah, Mohammad Bilal, Raiya Sarwar, Aasma Shaukat. An Assessment of the Feasibility, Patient Acceptance, and Performance of Point-of-Care Transient Elastography for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-Analysis. Diagnostics 2024; 14(22): 2478 doi: 10.3390/diagnostics14222478
|
| 28 |
Shima Sharifi, Mohammad Bagherniya, Ziba Khoram, Amrollah Ebrahimi Varzaneh, Stephen L. Atkin, Tannaz Jamialahmadi, Amirhossein Sahebkar, Gholamreza Askari. Efficacy of curcumin plus piperine co‐supplementation in moderate‐to‐high hepatic steatosis: A double‐blind, randomized, placebo‐controlled clinical trial. Phytotherapy Research 2023; 37(6): 2217 doi: 10.1002/ptr.7764
|
| 29 |
Fei Fei Shen, Lun Gen Lu. Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease. Journal of Digestive Diseases 2016; 17(9): 565 doi: 10.1111/1751-2980.12384
|
| 30 |
Jing Zeng, Xi Zhang, Chao Sun, Qin Pan, Wen-Yi Lu, Qian Chen, Li-Su Huang, Jian-Gao Fan. Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years. BMC Pediatrics 2019; 19(1) doi: 10.1186/s12887-019-1487-6
|
| 31 |
Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. Journal of Clinical and Experimental Hepatology 2019; 9(1): 13 doi: 10.1016/j.jceh.2018.02.010
|
| 32 |
Emanuella De Lucia Rolfe, Soren Brage, Alison Sleigh, Francis Finucane, Simon J. Griffin, Nick J. Wareham, Ken K. Ong, Nita G. Forouhi, Ferruccio Bonino. Validity of ultrasonography to assess hepatic steatosis compared to magnetic resonance spectroscopy as a criterion method in older adults. PLOS ONE 2018; 13(11): e0207923 doi: 10.1371/journal.pone.0207923
|
| 33 |
Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica, Amedeo Lonardo. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Review of Gastroenterology & Hepatology 2015; 9(5): 603 doi: 10.1586/17474124.2015.1007955
|
| 34 |
Marianthi Papagianni, Areti Sofogianni, Konstantinos Tziomalos. Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. World Journal of Hepatology 2015; 7(4): 638-648 doi: 10.4254/wjh.v7.i4.638
|
| 35 |
Richard K. Sterling, Andres Duarte-Rojo, Keyur Patel, Sumeet K. Asrani, Mouaz Alsawas, Jonathan A. Dranoff, Maria Isabel Fiel, M. Hassan Murad, Daniel H. Leung, Deborah Levine, Tamar H. Taddei, Bachir Taouli, Don C. Rockey. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 2024; doi: 10.1097/HEP.0000000000000843
|
| 36 |
Thomas Karlas, David Petroff, Magali Sasso, Jian-Gao Fan, Yu-Qiang Mi, Victor de Lédinghen, Manoj Kumar, Monica Lupsor-Platon, Kwang-Hyub Han, Ana C. Cardoso, Giovanna Ferraioli, Wah-Kheong Chan, Vincent Wai-Sun Wong, Robert P. Myers, Kazuaki Chayama, Mireen Friedrich-Rust, Michel Beaugrand, Feng Shen, Jean-Baptiste Hiriart, Shiv K. Sarin, Radu Badea, Kyu Sik Jung, Patrick Marcellin, Carlo Filice, Sanjiv Mahadeva, Grace Lai-Hung Wong, Pam Crotty, Keiichi Masaki, Joerg Bojunga, Pierre Bedossa, Volker Keim, Johannes Wiegand. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. Journal of Hepatology 2017; 66(5): 1022 doi: 10.1016/j.jhep.2016.12.022
|
| 37 |
Rishi Philip Mathew, Sudhakar Kundapur Venkatesh. Imaging of Hepatic Fibrosis. Current Gastroenterology Reports 2018; 20(10) doi: 10.1007/s11894-018-0652-7
|
| 38 |
Yong-ho Lee, Jae Hyeon Kim, So Ra Kim, Heung Yong Jin, Eun-Jung Rhee, Young Min Cho, Byung-Wan Lee. Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness. Journal of Korean Medical Science 2017; 32(1): 60 doi: 10.3346/jkms.2017.32.1.60
|
| 39 |
|
| 40 |
Adam C. Winters, Rasham Mittal, Thomas D. Schiano. A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post–liver transplant patient. Clinical Transplantation 2019; 33(10) doi: 10.1111/ctr.13700
|
| 41 |
Jayanta PAUL, Raj Vigna VENUGOPAL, Lorance PETER, Kula Naresh Kumar SHETTY, Mohit P SHETTI. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY. Arquivos de Gastroenterologia 2018; 55(1): 7 doi: 10.1590/s0004-2803.201800000-07
|
| 42 |
Cayden Beyer, Chloe Hutton, Anneli Andersson, Kento Imajo, Atsushi Nakajima, Dustin Kiker, Rajarshi Banerjee, Andrea Dennis, Wan-Long Chuang. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort. PLOS ONE 2021; 16(4): e0249491 doi: 10.1371/journal.pone.0249491
|
| 43 |
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
|
| 44 |
Yaohui Wang, Yuhua Zeng, Changwei Lin, Zhiheng Chen. Hypertension and non‐alcoholic fatty liver disease proven by transient elastography. Hepatology Research 2016; 46(13): 1304 doi: 10.1111/hepr.12688
|
| 45 |
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Application of transient elastography in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2020; 26(2): 128 doi: 10.3350/cmh.2019.0001n
|
| 46 |
Yong-ho Lee, Kwang Joon Kim, Myung eun Yoo, Gyuri Kim, Hye-jin Yoon, Kwanhyeong Jo, Jong-Chan Youn, Mijin Yun, Jun Yong Park, Chi Young Shim, Byung-Wan Lee, Seok-Min Kang, Jong-Won Ha, Bong-Soo Cha, Eun Seok Kang. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. Journal of Hepatology 2018; 68(4): 764 doi: 10.1016/j.jhep.2017.11.023
|
| 47 |
Tso‐Tsai Liu, He Qiu, Shi‐Yu Liu, Chieh Chien, Jen‐Hung Wang, Ming‐Wun Wong, Chih‐Hsun Yi, Lin Lin, Wei‐Yi Lei, Shu‐Wei Liang, Jui‐Sheng Hung, Jee‐Fu Huang, Chien‐Lin Chen, Ma Ai Thanda Han. Modifications decrease hepatic steatosis in Taiwanese with metabolic‐associated fatty liver disease. The Kaohsiung Journal of Medical Sciences 2022; 38(10): 1012 doi: 10.1002/kjm2.12580
|
| 48 |
Ebada Said, Muhammad Abdel-Gawad, Eman Abdelsameea, Eman Elsayed Elshemy, Nermeen Abdeen, Mohamed Elbasiony, Dalia Omran, Yasser Elesnawy, Alshaimaa Eid, Sameh A. Lashen, Osama Elbahr, Gina Gamal Naguib, Shimaa Afify, Eshak I. Bahbah, Mohamed Alboraie. Vibration Controlled Transient Elastography in Screening for Silent Liver Diseases. European Journal of Gastroenterology & Hepatology 2023; 35(10): 1204 doi: 10.1097/MEG.0000000000002620
|
| 49 |
Parambir S. Dulai, Claude B. Sirlin, Rohit Loomba. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. Journal of Hepatology 2016; 65(5): 1006 doi: 10.1016/j.jhep.2016.06.005
|
| 50 |
Young Eun Chon, Kyu Sik Jung, Kwang Joon Kim, Dong Jin Joo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim. Normal Controlled Attenuation Parameter Values: A Prospective Study of Healthy Subjects Undergoing Health Checkups and Liver Donors in Korea. Digestive Diseases and Sciences 2015; 60(1): 234 doi: 10.1007/s10620-014-3293-1
|
| 51 |
Christiane Stern, Laurent Castera. Non-invasive diagnosis of hepatic steatosis. Hepatology International 2017; 11(1): 70 doi: 10.1007/s12072-016-9772-z
|
| 52 |
Nimantha M.W. de Alwis. Practical Guide to Obesity Medicine. 2018; : 89 doi: 10.1016/B978-0-323-48559-3.00009-9
|
| 53 |
Nicolás Salva-Pastor, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Jorge Román Audifred-Salomón, Danniela Niebla-Cárdenas, Rafael Topete-Estrada, Helga Pereznuñez-Zamora, Rafael Vidaltamayo-Ramírez, Margarita Elodia Báez-Arellano, Misael Uribe, Natalia Nuño-Lámbarri. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population. Annals of Hepatology 2020; 19(3): 251 doi: 10.1016/j.aohep.2020.01.004
|
| 54 |
Yu-Qiang Mi, Qi-Yu Shi, Liang Xu, Rui-Fang Shi, Yong-Gang Liu, Ping Li, Feng Shen, Wei Lu, Jian-Gao Fan. Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B. Digestive Diseases and Sciences 2015; 60(1): 243 doi: 10.1007/s10620-014-3341-x
|
| 55 |
Shujing Lv, Sushan Jiang, Shousheng Liu, Quanjiang Dong, Yongning Xin, Shiying Xuan. Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2018; 6(2): 217 doi: 10.14218/JCTH.2018.00021
|
| 56 |
Na Di, Xinchuan Zhou, Yaxiao Chen, Xiaomiao Zhao, Lin Li, Linlin Jiang, Baoming Luo, Xiaoli Chen, Dongzi Yang. Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?. Archives of Endocrinology and Metabolism 2019; doi: 10.20945/2359-3997000000119
|
| 57 |
Marie Boyle, Quentin M. Anstee. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 523 doi: 10.1002/9781119211419.ch35
|
| 58 |
Feng Shen, Rui‐Dan Zheng, Jun‐Ping Shi, Yu‐Qiang Mi, Guo‐Feng Chen, Xiqi Hu, Yong‐Gang Liu, Xiao‐Ying Wang, Qin Pan, Guang‐Yu Chen, Jian‐Neng Chen, Liang Xu, Rui‐Nan Zhang, Lei‐Ming Xu, Jian‐Gao Fan. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease. Liver International 2015; 35(11): 2392 doi: 10.1111/liv.12809
|
| 59 |
Preya Janubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Nigel Neil Brown, Nivene Saad, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, Anthony William Russell, Elizabeth Ellen Powell. Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. Journal of Diabetes and its Complications 2018; 32(8): 799 doi: 10.1016/j.jdiacomp.2018.05.008
|
| 60 |
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis. Gene Expression 2019; 19(3): 187 doi: 10.3727/105221619X15553433838609
|
| 61 |
Xiudong Shi, Wen Ye, Fengjun Liu, Rengyin Zhang, Qinguo Hou, Chunzi Shi, Jinhua Yu, Yuxin Shi. Ultrasonic liver steatosis quantification by a learning-based acoustic model from a novel shear wave sequence. BioMedical Engineering OnLine 2019; 18(1) doi: 10.1186/s12938-019-0742-2
|
| 62 |
|
| 63 |
Satoshi Oeda, Kenichi Tanaka, Ayaka Oshima, Yasue Matsumoto, Eisaburo Sueoka, Hirokazu Takahashi. Diagnostic Accuracy of FibroScan and Factors Affecting Measurements. Diagnostics 2020; 10(11): 940 doi: 10.3390/diagnostics10110940
|
| 64 |
Kee-Huat Chuah, Wah-Kheong Chan. Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance. Current Hepatology Reports 2019; 18(4): 492 doi: 10.1007/s11901-019-00493-x
|
| 65 |
Syunichiro Kimura, Kenichi Tanaka, Satoshi Oeda, Kaori Inoue, Chika Inadomi, Yoshihito Kubotsu, Wataru Yoshioka, Michiaki Okada, Hiroshi Isoda, Takuya Kuwashiro, Takumi Akiyama, Aya Kurashige, Ayaka Oshima, Mayumi Oshima, Yasue Matsumoto, Atsushi Kawaguchi, Keizo Anzai, Eisaburo Sueoka, Shinichi Aishima, Hirokazu Takahashi. Effect of skin–capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94970-3
|
| 66 |
Manar N. Amin, Muhammad A. Rushdi, Raghda N. Marzaban, Ayman Yosry, Kang Kim, Ahmed M. Mahmoud. Wavelet-based computationally-efficient computer-aided characterization of liver steatosis using conventional B-mode ultrasound images. Biomedical Signal Processing and Control 2019; 52: 84 doi: 10.1016/j.bspc.2019.03.010
|
| 67 |
Liang Xu, Wei Lu, Ping Li, Feng Shen, Yu-Qiang Mi, Jian-Gao Fan. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B. Digestive and Liver Disease 2017; 49(8): 910 doi: 10.1016/j.dld.2017.03.013
|
| 68 |
Noel C. Salvoza, David C. Klinzing, Juliet Gopez-Cervantes, Michael O. Baclig, Manlio Vinciguerra. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease. PLOS ONE 2016; 11(4): e0153497 doi: 10.1371/journal.pone.0153497
|
| 69 |
Magali Sasso, Stéphane Audière, Astrid Kemgang, Farid Gaouar, Christophe Corpechot, Olivier Chazouillères, Céline Fournier, Olivier Golsztejn, Stéphane Prince, Yves Menu, Laurent Sandrin, Véronique Miette. Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy. Ultrasound in Medicine & Biology 2016; 42(1): 92 doi: 10.1016/j.ultrasmedbio.2015.08.008
|
| 70 |
Elena N. Shirokova, Chavdar S. Pavlov, Anna D. Karaseva, Aliya M. Alieva, Alla V. Sedova, Vladimir T. Ivashkin. Elastography in the Diagnosis of Non-Alcoholic Fatty Liver Disease. Annals of the Russian academy of medical sciences 2019; 74(1): 5 doi: 10.15690/vramn1071
|
| 71 |
|
| 72 |
Feng Shen, Yu‐Qiang Mi, Liang Xu, Yong‐Gang Liu, Xiao‐Ying Wang, Qin Pan, Rui‐Nan Zhang, Xi‐Qi Hu, Lei‐Ming Xu, Jian‐Gao Fan. Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. Alimentary Pharmacology & Therapeutics 2019; 50(1): 93 doi: 10.1111/apt.15298
|
| 73 |
Mohammad S. Kuchay, Narendra S. Choudhary, Deepak Sharma, Sonal Krishan, Sunil K. Mishra, Jasjeet S. Wasir, Manish K. Singh, Neeraj Saraf, Swapnil Dhampalwar, Randhir Sud. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population. Journal of Clinical and Experimental Hepatology 2022; 12(3): 893 doi: 10.1016/j.jceh.2021.10.003
|
| 74 |
Junghoan Park, Jeong Min Lee, Gunwoo Lee, Sun Kyung Jeon, Ijin Joo. Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques. Korean Journal of Radiology 2022; 23(1): 13 doi: 10.3348/kjr.2021.0112
|
| 75 |
Naoyuki Fujimori, Naoki Tanaka, Soichiro Shibata, Kenji Sano, Tomoo Yamazaki, Tomohiro Sekiguchi, Hiroyuki Kitabatake, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non‐alcoholic fatty liver disease with none‐to‐mild obesity and liver fibrosis. Hepatology Research 2016; 46(10): 1019 doi: 10.1111/hepr.12649
|
| 76 |
Body mass index–based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease. Indian Journal of Gastroenterology 2020; 39(1): 32 doi: 10.1007/s12664-019-00991-2
|